Immunitybio Inc (($IBRX)) announced an update on their ongoing clinical study. ImmunityBio Inc. is conducting a study titled ‘Single Arm Study to ...

Scientists have found protein fragments from the COVID-19 virus hidden inside tiny cellular packages in the blood of long ...

Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scien ...

But researchers are pressing ahead with new clinical trials for more targeted treatments built on advances in our understanding of long covid. There’s now a large body of research on the condition.

There’s a host of pharmaceuticals that have promising off-label uses for long covid, said microbiologist Amy Proal, president and chief scientific officer at the Massachusetts-based PolyBio Research ...

There is a need to consolidate various long COVID definitions to establish a standardized definition that ensures consistent recognition, documentation, diagnosis, and treatment, according to new ...

MaineHealth is participating in two new clinical trials sponsored by the National Institutes of Health to investigate potential treatments for ‘long-term’ COVID-19 symptoms.

For example, current long COVID clinical trials are testing 5 to 15 days of antivirals like Paxlovid. But treatment of persistent hepatitis C virus requires 8 to 12 weeks of antiviral therapy.

In December 2020, Congress approved $1.15 billion for the NIH to research and test treatments for long COVID. The new clinical trials are phase 2, meant to test safety and effectiveness.

Without clinical trials, physicians specializing in treating long COVID must rely on hunches to guide their clinical decisions, said Ziyad Al-Aly, MD, chief of research and development with the VA ...

Without clinical trials, physicians specializing in treating long covid must rely on hunches to guide their clinical decisions, said Ziyad Al-Aly, chief of research and development with the VA St ...